WEDNESDAY, April 30, 2025 (HealthDay News) — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study published online March 17 in Scientific Reports. Yasuhiro Suzuki, from University of Tsukuba in Japan, and colleagues examined the association of SGLT2 inhibitors and glucagon-like […]
The post Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes first appeared on Physician’s Weekly.
